J. Goldman & Co’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

J. Goldman & Co’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-129,500	Closed	-$4.71M	–	471
2016 Q4	$4.71M	Buy	129,500 +51,324	+66%	+$1.82M	0.31%	102
2016 Q3	$2.98M	Buy	+78,176	New	+$1.16M	0.17%	157

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

J. Goldman & Co's CLCD Position: Q1 2017 in Review

J. Goldman & Co sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 129,500 shares — an estimated $4.71M sold.

J. Goldman & Co first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $4.71M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

J. Goldman & Co reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
J. Goldman & Co sold 129,500 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $4.71M.
J. Goldman & Co first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
J. Goldman & Co's CoLucid Pharmaceuticals, Inc. position peaked at $4.71M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on J. Goldman & Co's 13F filing for Q1 2017, filed 15 May 2017.